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Terminal deoxynucleotidyl transferase (TdT) 1 is an intracellular enzyme that can 
catalyze  the  polymerization  of  any  3'-OH-terminated  segment  of  DNA  without 
template direction (1). In rat and mouse, TdT  is present  in the majority of cortical 
thymocytes and in a  minority of nucleated cells from bone marrow and prepubertal 
spleen, liver, and blood (2-6) (R. Sasaki, F.J. Bollum, and I. Goldschneider. Transient 
populations of terminal deoxynucleotidyl transferase-positive cells in rats and mice. 
Manuscript  in preparation.). It is also present in most  cases of acute lymphoblastic 
leukemia  (ALL)  in  man  and  mouse,  and  in  some  cases  of chronic  myelogenous 
leukemia  in  blast  crisis  (7,  8).  Because  of its  restricted  distribution  and  unusual 
biochemical properties, it has been postulated that TdT  may function as a  somatic 
mutagen during the early stages of lymphocyte differentiation (9,  10). 
There is strong evidence that many TdT + hemopoietic cells are thymocyte progen- 
itors (11).  Approximately 50% of TdT ÷ cells in normal mouse bone marrow  can be 
induced to express Thy-1 antigen by incubation in vitro with thymopoietin (12); and 
>75%  of TdT ÷  cells  in  bone  marrow  and  spleen  from  normal  and  congenitally 
athymic (nu/nu)  mice can be induced to express Ly-1,2,3 antigens by incubation with 
thymosin.  2 TdT  also has been detected in most  cases of human  pre-B cell leukemia 
(i.e., cytoplasmic Ig  ÷, surface Ig-) (13,  14)  and in a  small percentage of pre-B cells in 
normal human  (15) and mouse (16) bone marrow. This suggests that some TdT ÷ cells 
may be B cell progenitors or lymphoid stem cells. 
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Studies to test these hypotheses directly would be aided by the availability of highly 
enriched populations of viable TdT ÷ cells, especially if such populations were devoid 
of pluripotent hemopoietic stem cells. This is accomplished in the present study, in 
which the fluorescence-activated cell sorter (FACS)  (17)  is used to isolate TdT ÷ cells 
from normal rat bone marrow. 
Materials  and  Methods 
All materials and methods used in this study are described elsewhere (18),  except for the 
following. 
Immunofluorescence Assay  for TdT.  An IgG fraction of rabbit antiserum to homogenous calf 
TdT  was  rendered  highly  specific  by  elution  from  a  TdT-immunoadsorbant  column  as 
described previously (3, 19). The anti-TdT was used at a concentration of 200 #g of protein/ml 
of Eisen's balanced salt solution.  Fluorescein-conjugated goat  IgG  against  rabbit  IgG was 
obtained from N. L. Cappel Laboratories Inc., Cochranville, Pa. 
Cell smears were prepared in a  cytocentrifuge (Cytospin; Shandon  Southern Instruments 
Inc., Sewickley, Pa.), fixed for 5 min  in cold, absolute methanol, and processed for indirect 
immunofluorescence  as described previously (3).  Percentages of TdT  + cells were  based  on 
examination of 1,000 nucleated cells/sample. 
Results 
Dtstnbution of TdT  ÷ Cells by FACS Analysis 
LOW-ANGLE  LIGHT SCATTER.  Approximately  97%  of TdT +  cells  from  rat  bone 
marrow were present between the peaks formed by lymphocytes (peak II) and myeloid 
cells (peak III); 81% of the TdT + cells were concentrated in a  30-channel window at 
the base of the valley between  these two  peaks  (Fig.  1,  fraction  B;  the entire  light 
scatter distribution comprised 256  channels). Collection of this fraction, which con- 
tained  ~ 14%  of the total nucleated bone marrow cells, resulted  in  a  mean  4.9-fold 
enrichment  in TdT + cells (Table I). Any substantial enlargement of this window to 
the  left  or  right  resulted  in  slightly  greater  recovery  of  total  TdT +  cells  but  in 
significantly lesser enrichment. Therefore, all further purification was restricted to the 
cells in fraction B. 
RELATIVE FLUORESCENCE  INTENSITY  FOR  THY-I  ANTIGEN.  As reported previously (3), 
all TdT + cells in rat bone marrow are Thy-1 +.  Results in Fig. 2  and Table II show 
,q 
_a  Tr 
o¢ 
RELATIVE LIGHT SCATTER 
F,o  1  Relauve size distribution of rat bone marrow cells as determ,ned by low-angle light scatter 
on  the  FACS.  Roman  numerals  designate  lymphoid  (II)  and  myelo,  d  (III)  cell  peaks  (18). 
Erythrocytes (formerly peak I) were lysed with 0.168 M NH4CI Vertical threshold markers delineate 
cell fractions (capital letters) that were separated In th,s figure, fracuon B contained 12 8% of total 
nucleated cells and 81 7% of total TdT  + cells 440  ISOLATION  OF  TERMINAL  TRANSFERASE-POSITIVE  CELLS 
TABLE  I 
Dtstrzbutzon of TdT  + Cells m Rat Bone Marrow According to Relat,ve  Low-Angle Ltght Scatter 
Percentage of TdT  ÷  Percentage of  Enrichment§ 
Fracuon (%)*  cells/fractlonZ~  total TdT  ÷ cells 
%  % 
I  (<1)  00  00  <1 
IIL  (30+65)  00  00  <l 
IIR  (24+--36)  50+08  521  23 
IIIL  (22±36)  49±0.8  449  22 
IIIR  (24±39)  03:1:01  30  <1 
A  (503±17)  07+02  166  <1 
B  (143+15)  108+17  732  49 
C  (354+25)  06+01  101  <1 
UnfractionatedJJ  2 2 +  0 5 
* See F,g  1 for detads  L, left half of peak, R, right half of peak  Numbers m parentheses refer to percentage 
of total nucleated cells 
:~ Determined by Jmmunofluorescence for TdT  Mean ±  SD of four to six experiments 
§ Number of times greater than value m unfractlonated bone marrow cells 












FiG  2  Relatwe fluorescence  distribution of rat bone marrow cells incubated with rabbit fluores- 
cem isothlocyanate-conjugated F(ab')2 anti-Thy-I serum  FACS analysis of cells m fraction B (Fig 
1)  The numbers m parentheses indicate percentde of fluorescent cells m dehneated fracttons  Note 
that the cells m the upper 25th percentde ofThy-1 + cells form a distract shoulder to the right of the 
mare peak  In th~s figure, 84 9% of the cells m the upper 25th percenttle were TdT  + 
that  91%  of the TdT +  cells  in  fraction  B  are  in  the upper  50th  percentile  for Thy-1 
fluorescence,  and  that  78%  are in the upper  25th  percentile.  Collection  of this latter 
fraction yielded  cell suspenstons that contained  a  mean  of 84.5%  TdT ÷ cells  (Fig.  3), 
which represents a  45-fold enrichment  over levels in unfractionated  bone marrow 
In addition to TdT + cells, pluripotent  hemopoietic stem cells (PHSC)  were enriched 
-52-fold  by the above  fracttonation  procedure.  However,  PHSC  are restricted to the 
upper  10th percentile ofThy-1  + cells (18).  Hence, by collecting only those cells in the 
76-90th  percentile for Thy-1  fluorescence,  suspensions were obtained  that contained 
a  mean  of 87%  TdT +  cells but  <0.2%  in  vivo spleen  colony-forming  umts  (CFU-S) 
(assuming a  seeding efficiency of 0  01) I.  GOLDSCIHNEIDER, D.  METCALF,  T.  MANDEL,  AND  F.  J  BOLLUM  441 
TABLE  II 
Dtstrtbutzon  of TdT + Cells m  Rat Bone Marrow According to Relatwe Fluorescence Intenstty for Thy-1 
Antigen 
Thy- 1  ÷ cells percenule*  Percentage of TdT  +  Percentage of total 
cells/fraction:l:  TdT  + cells§  Enrichmentll 
%  % 
91-100  83 2 ::1:6.1  30 3  43 8 
76--90  86.6 ::l: 5 9  47.4  45 6 
76-100  84 5 :t: 5.0  77.7  44 5 
1-75  8.1:1:2.7  223  43 
51-100  56 1:1:9 1  91 2  29 5 
1-50  54+2.7  88  28 
Total Thy-I  +  31.4 +  5 8  100 0  16 5 
Total Thy- 1-  0 0  0 0  < 1 
Unfractionated¶  1.9 +  0 5 
* Cells m fraction B (Fig  1 and Table I) were sorted into Thy-I  ÷ (fluorescent) and Thy-1- (nonfluorescent) 
populations on the FACS. The Thy-I  + cells were sorted further according to relauve fluorescence intensity 
(Fig  2) 
~: Determined by tmmunofluorescenee for TdT  Mean +  SD of four to six experiments 
§ Fraction B 
][ Number of umes greater than value m unfractlonated bone marrow 
¶ Not processed on the FACS 
FIG.  3  Smears of FACS-separated rat bone marrow cells developed for lmmunofluorescence with 
antibodies to TdT  The unfractmnated bone marrow contained  I 7% TdT  + cells.  (a)  Cells  from 
fraction B,  1-75th  percentile for Thy-1  fluorescence  Note single TdT  + cell  (nuclear fluorescence) 
and numerous TdT- cells  (appear as pale grey ghosts)  3 ~  of cells in this fraction were TdT  +  (b) 
Cells from fraction B, 76-100th percentile for Thy-I fluorescence  81% of cells  in this fraction were 
TdT  +  x  560 4-4:2  ISOLATION OF TERMINAL TRANSFERASE-POSITIVE CELLS 
Pretreatment of the donor rats with cortisone caused a  96% decrease of TdT  + cells 
in the 76-100th percentile of Thy- 1  + cells in fraction B. 
Morphology of TdT  + Cells 
TdT  + cells have a characteristic appearance by light microscopy (Fig. 4). The cells 
superficially resemble large  lymphocytes, but  have a  slightly  eccentric,  sharply  in- 
dented,  leptochromatic  nucleus,  multiple  nucleoli,  a  prominent  Golgi  zone,  and 
moderately abundant cytoplasm with a prominent basophilic rim. The mean diameter 
ofTdT + cells in fraction B  (upper 25th percentile ofThy-1 + cells) was 10.4 3=  1.8 #m. 
Most of the TdT- cells in the 91-100th percentile of Thy-1  + cells in fraction B were 
large undifferentiated  mononuclear cells that  had  the morphological characteristics 
of candidate PHSC  (18).  The percentage of these cells increased from  11  to 56 after 
treatment with cortisone. Almost all of the TdT-  cells in the  76-90th  percentile of 
Thy-1 + cells in fraction B were polychromatophilic erythroblasts. 
The  Thy-1  +  cells  in  the  lower  75th  percentile  of fraction  B  were  a  mixture  of 
medium size lymphocytes (73%)  and erythroblasts (27%). 
The ultrastructural properties of candidate TdT  + cells are shown in Fig. 5. 
Discussion 
Most  schemes of lymphopoiesis envision  the  existence of discrete  populattons  of 
lymphoid stem and/or  progenitor cells.  However, attempts to  functionally demon- 
strate these cells have been complicated by the presence of PHSC. This problem has 
been partially obviated by the  study of Abramson et  al.  (20),  who described chro- 
mosomally marked clones of T  cell progenitors. However, these authors were unable 
to demonstrate clones of B cell progenitors or multipotent lymphoid stem cells, thus 
prompting the speculation that PHSC may subserve these functions. Other authors 
have  noted  that  the  lymphoid  and  myeloid-erythroid  cell  series  diverge  early  in 
hemopoiesis (21-23), further emphasizing the developmental proximity of primitive 
lymphocyte precursors to PHSC. Therefore, in attempting to identify TdT  ÷ cells as 
lymphocyte progenitors,  it  is  essential  to  demonstrate  that  they  are  not  PHSC  or 
myeloid-erythroid cell precursors. 
As  shown  in  Fig.  6,  TdT  + cells can  be completely separated  from  granulocyte- 
FIG  4  Candidate TdT  ÷ cells from rat bone marrow. May-Grunwald-Glemsa  stare  (a and b) 
Representauve cells from suspensions containing 87% and 92% TdT  + cells, respecuvely Note rim 
of basophihc cytoplasm,  prominent Golgi zone, and indented, moderately leptochromatic nucleus 
Nucleoh are not well vtsualized in these photographs but were typically present (Fig 5)  × 775 I  GOLDSCHNEIDER,  D.  METCALF, T  MANDEL, AND F  J  BOLLUM  443 
FIa  5  Electron micrograph of candidate  TdT  + cell The typical features of the cells m this 
populauon are their generally leptochromatic nuclei with prominent nucleoli, relatively abundant 
cytoplasm that  contains numerous monoribosomes, a  well developed Golgi zone and adjacent 
centriole, and some mitochondna  Other organelles are sparse or absent. × 7,000 
,..,.I 





RELATIVE LIGHT  SCATTER 
Fio. 6.  Relative size distribution of lymphohemopoletic precursor cells from rat bone marrow as 
determined by low-angle hght scatter on the FACS. The arrows designate the position of TdT  + 
cells, CFU-S, and GM-CFC relative to each other  and to  total  nucleated bone  marrow cells 
(reference curve). Mean diameters (pm) =t= SD were determined on cytocentrifuge  smears of ennched 
fractions as described in this paper and elsewhere (18) The distance between the markings on the 
abscissa represent ~ 1 #m. 
macrophage  (GM)  in vitro colony-forming cells  (CFC)  (GM-CFC) on the basis of 
relative light scatter, TdT + cells being much smaller than GM-CFC (18). Eosinophil 
(EO)  and  megakaryocyte  (MEG)  progenitors  (EO-CFC  and  MEG-CFC)  also  are 
larger than TdT + cells (I. Goldschneider. Unpublished observations.). Although the 
relationship between TdT + cells and erythrocyte progenitor cells (erythroid CFU and 
erythroid burst-forming unit) was not formally tested, other studies have shown that 
erythrocyte  progenitor cells  are  larger  than  PHSC  (24),  and,  hence,  they  almost 
certainly are larger than TdT + cells (see below). 
TdT +  cells  and  PHSC  overlap  considerably with  respect  to  relative  size  and 
fluorescence intensity for Thy- 1 antigen (Fig. 6) (18). However, TdT + cells are slightly 
smaller on average (mean diameter  10.4 #m)  than are PHSC  (mean diameter  11.2 444  ISOLATION OF TERMINAL TRANSFERASE-POSITIVE CELLS 
#m) and have a broader representation among Thy-1 + cells (upper 25th percentile vs. 
upper 10th percentile). Therefore, it is possible to separate about one-half of the TdT  + 
cells in fraction B from PHSC: on the basis of relative fluorescence intensity for Thy- 
1 antigen.  That  the  remainder of the TdT  + cells  (upper  10th  percentile  for Thy-1 
fluorescence) are also distinct from PHSC is shown by their differential sensitivity to 
cortisone, TdT  + cells being sensitive and PHSC being resistant  (18).  The fact that 
PHSC  candidates  in  fraction  B  increased  approximately  fivefold  after  cortisone 
treatment indicates that cortisone acts to physically deplete the population of TdT  + 
cells, rather than simply to interfere with the biosynthesis of TdT. 
The fractionation procedure that we have devised for isolating TdT  + cells is not 
ideal, inasmuch  as only 34% of total TdT  + cells are recovered. Nonetheless,  it does 
meet the major objective of providing a  highly enriched population of viable TdT  + 
cells  virtually  free from PHSC  and  myeloid progenitor  cells.  This  should  make  it 
possible to study the ability of TdT  ÷ cells to generate T  and/or  B cells in adoptive 
transfer systems. If, as seems likely, TdT  + cells are lymphocyte progenitors  and/or 
lymphoid  stem  cells,  the  ability  to  culture  them  in  vitro  (25)  (J.  Hayashi,  I. 
Goldschneider, and F. J.  Bollum. A  selective culture system for generating terminal 
deoxynucleotidyl  transferase-positive cells  tn  vttro.  Manuscript  in  preparation.)  and 
the availability of a  variety of T  and B cell-inducing agents may permit a  detailed 
analysis of the early stages of lymphocyte differentiation in vitro. 
A  second  area in which  the  availability of highly  enriched  populations of TdT  + 
cells may be useful is in the study of the pathogenesis of ALL. Most eases of ALL in 
human beings and mice are TdT  + (7, 8). However, it is not clear at what stages in the 
development of TdT  + cells neoplastic transformation occurs. Janossy et al. (15)  have 
reported that TdT  + cells in nonleukemic human bone marrow bear ALL-associated 
antigens, thus suggesting that they may be precursors of the common type (null cell, 
non-T,  and  non-B)  of  ALL.  By  using  Gross  murine  leukemia  virus  to  induce 
lymphocytic leukemia in rats, we have shown that the neoplastic TdT  + cells in thymus 
and blood contain a variant lactic dehydrogenase isoenzyme that normally ~s present 
in bone marrow but not in thymus.  3 Similarly, the levels of adenosine deaminase and 
purine nucleoside phosphorylase in  the leukemic cells are characteristic of those  in 
prethymic cells. Thus, it is possible that the target of neoplastic transformation is the 
TdT  +  bone  marrow cell  or  its  precursor.  Purification  of TdT  +  bone  marrow cells 
during the latent period of leukemogenesis may provide direct evidence in support of 
this hypothesis. 
Lastly, results of preliminary experiments indicate that the enriched population of 
TdT  + cells can be used  to raise specific antisera to surface antigens on TdT  + cells 
These antisera should be useful in further purifying TdT  + cells on the FACS and in 
tracing  the  development of TdT  +  cells.  Indeed,  one antiserum  has  been  shown  to 
react  selectively with  TdT  +  bone  marrow  cells  and  subcapsular  thymocytes,  thus 
suggesting that these two cell populations may have a precursor-product relationship 
(I. Goldschneider. Unpublished observation.). 
a Barton,  R  W,  and  I. Goldschneider  Evidence  for the  hemopoletlc origin  of Gross virus  reduced 
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Summary 
A  method  is  described  by which  highly enriched  populations  of viable  terminal 
deoxynucleotidyl  transferase-positive  (rdT +)  cells  can  be  isolated  from  rat  bone 
marrow by use of the fluorescence-activated cell sorter. Such cells have been postulated 
to be progenitors of thymocytes and, possibly, of B lymphocytes, and may serve as the 
targets of neoplastic transformation in acute lymphoblastic leukemia. The separation 
procedure  is  based  on  differences  in  relative  low-angle  light  scatter  and  relative 
fluorescence  intensity  for Thy-I  antigen  between  TdT +  cells  and  other  lymphohe- 
mopoietic  cell  populations  in  bone marrow.  Simultaneous  sorting of bone  marrow 
cells according to these two parameters  resulted in a  mean 87% purification of TdT + 
cells. The morphological characteristics of the isolated TdT + cells are described at the 
light and electron microscopic levels. 
We wish to acknowledge the excellent technical assistance of Mr. Roderick Mitchell. We are 
also grateful to Dr. Frank Battye for his expert advice and assistance in the operation of the 
fluorescence-activated cell sorter. 
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